Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. - Wikidata - wikimedia - TriplyDB

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.

http://www.wikidata.org/entity/Q40684856

about

Escape Velocity: Why the Prospect of Extreme Human Life Extension Matters Now Like it or not, life-extension research extends beyond biogerontology Does accumulation of advanced glycation end products contribute to the aging phenotype?Arterial Stiffness Gradient Diabetic Cardiovascular Disease Induced by Oxidative Stress Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular Disease Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.Proinflammation of aging central arteries: a mini-review Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease Regenerative therapies for diabetic microangiopathy Advanced glycation end products and diabetic complications Aortic Stiffness as a Surrogate Endpoint to Micro- and Macrovascular Complications in Patients with Type 2 Diabetes Proinflammation: the key to arterial aging Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy Pimagedine: a novel therapy for diabetic nephropathy.Intraoperative sRAGE kinetics. A new age-related outcome predictor of cardiac surgery.Left ventricular diastolic dysfunction in dialysis patients assessed by novel speckle tracking strain rate analysis: prevalence and determinants Localised micro-mechanical stiffening in the ageing aorta.The central arterial burden of the metabolic syndrome is similar in men and women: the SardiNIA Study.Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects RAGE signaling in inflammation and arterial aging.Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging.Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis.Arterial stiffness and cardiovascular therapy Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes.Arterial aging: a journey into subclinical arterial disease.Mechanisms of vascular aging: new perspectives.Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links.Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels.Clinical applications of arterial stiffness: therapeutics and pharmacology.Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults.Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.Arterial Stiffness Aminoguanidine prevents age-related aortic stiffening in Fisher 344 rats: aortic impedance analysis.Aminoguanidine prevents age-related deterioration in left ventricular-arterial coupling in Fisher 344 rats.

P2860

Q21092830-36678603-4C3F-4272-B8DE-932E8ED81E08 Q24537606-0FC8C325-CB86-4E6E-9881-500AA7A35013 Q24632710-EDE29DCC-AC53-49F1-AC8B-17D0CAB7FC9B Q26748007-DC8191E3-36B8-42DC-8A64-8CDF2F9ADD9A Q26778017-8D3C0E63-F368-4B27-837D-AD9D7CECA4E6 Q26781156-8B5E3F0D-8976-4A66-819C-4F5A81938298 Q26782422-F29E67BE-9BF7-4E75-B560-CD4674477B50 Q27007027-E2F1CCF1-19D2-4F4E-A8C0-27A07E56DFDE Q27015975-557AD1B9-5901-4E44-A99F-9C7F94513999 Q27024623-B5A99A4D-163C-440C-98D7-DAA2E3AC5D81 Q27027852-1535E883-2B87-41AA-BAC3-18FB45FE879A Q27687501-2A0C10F9-B82C-4DF3-B26C-19120E23A96D Q28074239-6C853447-6141-4F4B-A8F8-B2B5357413FD Q28395632-77837C31-87FD-4AE2-88CE-69556930C5C7 Q29248994-EADB4240-E990-4301-8958-EC839E799E01 Q30309168-69E4F8C7-A870-45DC-96C7-EB93C83D9314 Q30317651-6EF722B2-7CC5-44B5-A9ED-A55F27BB0EE6 Q30467327-3A5E8505-FB11-4399-90C7-32DEECA90242 Q30473383-68FDB468-DF01-4ADF-8A60-023EA12C54D6 Q30476619-F8D442BC-4FA8-45A9-83DF-20169C92A2E5 Q30496869-8C3F4A04-70A0-44B2-87BF-AD609068CF21 Q30696151-2A9AC8B9-1DC9-4A16-887B-DD91C89FEBC1 Q33346824-C47B4C33-BCB5-46DE-8462-31035B05828E Q33649275-ECE20BF8-5773-4504-8329-D3FC8624FBEE Q33691339-8EF2A549-96B6-4A21-8164-FFE45A58960D Q33746869-91A0244A-71B4-455E-B491-9CA9465BECF4 Q34079790-4D51CA4E-176D-4964-8820-7F5F94A1586C Q34099937-7CEFD37C-2CBB-43D6-9442-4A5E260E525E Q34144269-78E7F659-B5EE-44A5-879A-5CFC4C73BBCF Q34179571-B047AB92-27AF-4814-8005-5D6E3D208E1A Q34217710-66BBB2B9-1974-4774-85C5-B186856FB6DB Q34481838-248CC2E3-8EB3-4E8A-A689-FC00CEA14526 Q34493878-7B701EC4-3CF5-4652-B76A-F07ABD8AFF65 Q34647819-69BDAB2E-B5B3-4270-8A03-406F665E962B Q34664894-B0A7C965-2264-4C3E-945B-9BFA5C670C4F Q34885399-8582A9CF-DDEB-4933-892D-9A9B4235DB4A Q34981419-D80F8395-CC8E-4132-A960-688063AE1ED3 Q35043143-DE3A3232-4156-4E81-B714-1526B92E33EF Q35045662-84740FA7-4435-4ADA-946C-895BF1B90E2E Q35047489-0E51ED1B-CEEA-464E-A510-3CDC2FCD3923

P2860

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.

http://www.wikidata.org/entity/Q40684856

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.

@en

type

label

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.

@en

prefLabel

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.

@en

P1433

Q40684856-76515907-6B04-48CC-8FB2-672BC6602964

P1476

Q40684856-6787154D-8C4A-42DD-B05C-645F73A07A04

P2093

Q40684856-084FEF43-D97D-44A3-A9F4-694D0AEDB6C7

Q40684856-1576E62A-7E7F-41DB-8610-4B9440B34318

Q40684856-9377BD85-32D7-43DE-89B8-6AE4F6573719

Q40684856-AEFBDAA0-A429-4C69-AF32-5877B83DE31E

Q40684856-BB8FBCE6-9E6C-4791-8B57-BCDCFD16B96E

Q40684856-E6A384F2-EB6D-4253-8595-5891457BBE02

Q40684856-F0B8FBDA-1400-49B8-972F-7DF077B7BEFE

P304

Q40684856-C3208885-3E38-4038-B92E-5D6BF3EF8E3E

P31

Q40684856-1140D15B-E6D1-430E-BBD6-86AF141FFB3A

P356

Q40684856-FF9CD77F-D17A-429C-890B-F2EF261D1782

P407

Q40684856-884F31BB-C2E4-49BE-BF7A-0846E7597124

P433

Q40684856-614AB7A1-46BD-4B08-9F27-ECBA878481F5

P478

Q40684856-D8A9AC60-E015-43DD-B694-89DD08851725

P577

Q40684856-4A84F5C1-C290-41B4-B12D-2FF19708BB00

P5875

Q40684856-96809720-13FE-4985-91CD-4EB31A9FD3B7

P698

Q40684856-44479C98-5867-4A40-951E-01BFA25C36ED

P356

P1433

P1476

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.

@en

P2093

A R Capriotti

http://www.w3.org/2001/XMLSchema#string

A Scuteri

http://www.w3.org/2001/XMLSchema#string

D A Kass

http://www.w3.org/2001/XMLSchema#string

E G Lakatta

http://www.w3.org/2001/XMLSchema#string

E P Shapiro

http://www.w3.org/2001/XMLSchema#string

M Kawaguchi

http://www.w3.org/2001/XMLSchema#string

R C deGroof

http://www.w3.org/2001/XMLSchema#string

P304

1464-1470

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HC3801.097806

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2001-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11777501

http://www.w3.org/2001/XMLSchema#string

P698

11571237

http://www.w3.org/2001/XMLSchema#string